Literature DB >> 7108270

Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh.

B J Stoll, R I Glass, M I Huq, M U Khan, H Banu, J Holt.   

Abstract

The epidemiologic and clinical characteristics of 412 patients infected with Shigella from a systematic sample of approximately 100,000 patients attending Dacca Hospital, International Centre for Diarrhoeal Disease Research, Bangladesh, between December 1, 1979, and November 30, 1980, were reviewed. Shigella was isolated from 11.6% of the 3,550 patients in the sample and was the second most common isolate in patients over two years old. Two clinical presentations of shigellosis were found: (I) watery diarrhea occurring in younger children and associated with a shorter duration of illness and with more vomiting and dehydration and (2) dysentery with stool blood and abdominal pain. These different presentations may reflect two mechanisms in the pathogenesis of shigellosis or different stages of the disease. The most useful signs and symptoms for the diagnosis of shigellosis were stool with blood and abdominal pain in all patients and the absence of watery diarrhea and vomiting in patients over one year old. Simple visual inspection of stool for blood correctly identified 44% of all patients infected with Shigella.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108270     DOI: 10.1093/infdis/146.2.177

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

2.  Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines.

Authors:  A B Hartman; L L Van de Verg; H H Collins; D B Tang; N O Bendiuk; D N Taylor; C J Powell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

3.  Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes.

Authors:  Shohreh Farshad; Raheleh Sheikhi; Aziz Japoni; Ezzatollah Basiri; Abdolvahab Alborzi
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Measurement of fecal lactoferrin as a marker of fecal leukocytes.

Authors:  R L Guerrant; V Araujo; E Soares; K Kotloff; A A Lima; W H Cooper; A G Lee
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Authors:  L F Fries; A D Montemarano; C P Mallett; D N Taylor; T L Hale; G H Lowell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 6.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

7.  Detection of provisional serovars of Shigella dysenteriae and designation as S. dysenteriae serotypes 14 and 15.

Authors:  M Ansaruzzaman; A K Kibriya; A Rahman; P K Neogi; A S Faruque; B Rowe; M J Albert
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Interventions for the control of diarrhoeal diseases among young children: promotion of breast-feeding.

Authors:  R G Feachem; M A Koblinsky
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

9.  Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species.

Authors:  D R Morgan; H L DuPont; B Gonik; S Kohl
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

10.  Fecal leukocytosis, indium-111-labelled autologous polymorphonuclear leukocyte abdominal scanning, and quantitative fecal indium-111 excretion in acute gastroenteritis and enteropathogen carriage.

Authors:  T Kordossis; A E Joseph; J N Gane; C E Bridges; G E Griffin
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.